Home/Filings/4/0001562180-22-008412
4//SEC Filing

Thaler Bjorn B 4

Accession 0001562180-22-008412

CIK 0001404123other

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 5:55 PM ET

Size

9.2 KB

Accession

0001562180-22-008412

Insider Transaction Report

Form 4
Period: 2022-12-20
Thaler Bjorn B
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2022-12-20$16.72/sh6,116$102,23813,718 total
Footnotes (2)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
  • [F2]This transaction was executed in multiple trades at prices ranging from $16.70 to $16.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

1Life Healthcare Inc

CIK 0001404123

Entity typeother

Related Parties

1
  • filerCIK 0001800588

Filing Metadata

Form type
4
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 5:55 PM ET
Size
9.2 KB